Atrion Reports Second Quarter 2020 Results

Atrion Corporation announced that for the second quarter ended June 30, 2020, revenues totaled $38.0 million compared with $40.1 million for the same period in 2019.

ALLEN, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2020, revenues totaled $38.0 million compared with $40.1 million for the same period in 2019. Net income for the second quarter of 2020 totaled $8.6 million as compared to $9.7 million for the same period in 2019, with diluted earnings per share for the second quarter of 2020 at $4.68 compared to $5.18 for the second quarter of 2019.

Commenting on the Company’s quarterly results for the second quarter of 2020 compared to the same period last year, David A. Battat, President & CEO, stated, “The impact of the pandemic was felt in the second quarter with revenues and operating income lower by 5% and 8%, respectively, essentially the reverse image of the first quarter when revenues were up 5% and operating income was up 6%.” Mr. Battat explained, “The current year second quarter saw hospitals suspend elective surgeries to preserve ICU beds and other resources to deal with the anticipated deluge of Covid-19 patients. As a result, sales of our products used in elective procedures were lower by $3.7 million.” Mr. Battat added, “The net impact on overall sales was limited to $2.1 million thanks to our diversified product portfolio and the tireless efforts of my co-workers who kept our operations running throughout this period.”

Mr. Battat continued “With an effective tax rate 15% higher in this year’s quarter than the prior year’s second quarter, diluted EPS and net income were lower by 10% and 11%, respectively. During the quarter we purchased 12,158 shares of our common stock at an average cost of $641 per share. As of June 30, 2020, we continue to be debt free while holding $87.5 million in cash and short and long term investments.”

Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.

ATRION CORPORATION
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)

Three Months Ended
June 30,
Six Months Ended
June 30,
2020 2019 2020 2019
Revenues $ 37,968 $ 40,103 $ 81,563 $ 81,717
Cost of goods sold 20,499 21,511 44,226 44,422
Gross profit 17,469 18,592 37,337 37,295
Operating expenses 7,423 7,626 15,577 15,291
Operating income 10,046 10,966 21,760 22,004
Interest and dividend income 367 581 858 1,163
Other investment income (loss) 354 161 (673 ) 372
Income before income taxes 10,767 11,708 21,945 23,539
Income tax provision (2,162 ) (2,044 ) (4,443 ) (4,437 )
Net income $ 8,605 $ 9,664 $ 17,502 $ 19,102
Income per basic share $ 4.69 $ 5.21 $ 9.49 $ 10.30
Weighted average basic shares outstanding 1,835 1,854 1,844 1,854
Income per diluted share $ 4.68 $ 5.18 $ 9.47 $ 10.25
Weighted average diluted shares outstanding 1,839 1,864 1,849 1,863

ATRION CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands)

June 30, Dec. 31,
ASSETS 2020 2019
(Unaudited)
Current assets:
Cash and cash equivalents $ 24,099 $ 45,048
Short-term investments 6,574 23,766
Total cash and short-term investments 30,673 68,814
Accounts receivable 22,441 18,886
Inventories 45,805 42,093
Prepaid expenses and other 3,226 2,545
Total current assets 102,145 132,338

Long-term investments

56,871 31,772

Property, plant and equipment, net

87,867 84,606
Other assets 13,467 13,315
$ 260,350 $ 262,031
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities 15,443 11,274
Line of credit -- --
Other non-current liabilities 11,380 12,887
Stockholders’ equity 233,527 237,870
$ 260,350 $ 262,031

Contact:
Jeffery Strickland
Vice President and Chief Financial Officer
(972) 390-9800

Primary Logo

MORE ON THIS TOPIC